Alamar Biosciences, Inc. (California) (ALMR)

32.71 +0.10 (+0.31%) USD  |  NASDAQ  |  Sep 29, 11:20
More

Alamar Biosciences Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for ALMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
June 30, 2025 --
March 31, 2025 --

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
10X Genomics, Inc. Upgrade
Personalis, Inc. Upgrade
Adaptive Biotechnologies Corp. Upgrade
Champions Oncology, Inc. Upgrade
Medpace Holdings, Inc. Upgrade